Annemiek A van der Eijk, Jan Maarten Vrolijk, Bart L Haagmans. Show Affiliations »
Abstract
Mesh: See more » AdultAntibodies/bloodAntiviral Agents/immunologyAntiviral Agents/pharmacokineticsAntiviral Agents/therapeutic useHepatitis C, Chronic/drug therapyHepatitis C, Chronic/immunologyHumansInterferon alpha-2Interferon-alpha/immunologyInterferon-alpha/pharmacokineticsInterferon-alpha/therapeutic useMalePolyethylene Glycols/pharmacokineticsPolyethylene Glycols/therapeutic useRecombinant Proteins
Substances: See more » AntibodiesAntiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene Glycolspeginterferon alfa-2a
Year: 2006 PMID: 16554542 DOI: 10.1056/NEJMc052880
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245